[HTML] springer.com

[HTML][HTML] Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial

YM Arabi, AC Gordon, LPG Derde, AD Nichol… - Intensive care …, 2021 - Springer
Purpose To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill
patients with coronavirus disease 2019 (COVID-19). Methods Critically ill adults with COVID …
被引用次数：95 相关文章

Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.

YM Arabi, AC Gordon, LPG Derde, AD Nichol… - Intensive Care …, 2021 - europepmc.org
Purpose To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill
patients with coronavirus disease 2019 (COVID-19). Methods Critically ill adults with COVID …

Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial

YM Arabi, A Gordon, L Derde, AD Nichol… - Intensive Care …, 2021 - research.monash.edu
Purpose: To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill
patients with coronavirus disease 2019 (COVID-19). Methods: Critically ill adults with COVID …
[HTML] hal.science

[HTML][HTML] Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial

Y Arabi, A Gordon, L Derde, A Nichol, S Murthy… - Intensive Care …, 2021 - hal.science

Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.

YM Arabi, AC Gordon, LPG Derde, AD Nichol, S Murthy… - 2021 - ses.library.usyd.edu.au
PURPOSE: To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill
patients with coronavirus disease 2019 (COVID-19). METHODS: Critically ill adults with …

Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial

YM Arabi, AC Gordon, LPG Derde… - Intensive Care …, 2021 - researchnow.flinders.edu.au
Purpose: To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill
patients with coronavirus disease 2019 (COVID-19). Methods: Critically ill adults with COVID …

Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial

REMAP-CAP Investigators - Intensive care …, 2021 - researchinformation.amsterdamumc …
Purpose: To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill
patients with coronavirus disease 2019 (COVID-19). Methods: Critically ill adults with COVID …

Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial

REMAP-CAP Investigators - Intensive Care Medicine, 2021 - research.ed.ac.uk
PURPOSE: To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill
patients with coronavirus disease 2019 (COVID-19). METHODS: Critically ill adults with …
[HTML] nih.gov

[HTML][HTML] Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial

YM Arabi, AC Gordon, LPG Derde… - Intensive Care …, 2021 - ncbi.nlm.nih.gov
Purpose To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill
patients with coronavirus disease 2019 (COVID-19). Methods Critically ill adults with COVID …

Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial

YM Arabi, AC Gordon, DL PG, AD Nichol… - Intensive Care …, 2021 - search.proquest.com
Purpose To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill
patients with coronavirus disease 2019 (COVID-19). Methods Critically ill adults with COVID …